1. Home
  2. VERA vs AVPT Comparison

VERA vs AVPT Comparison

Compare VERA & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • AVPT
  • Stock Information
  • Founded
  • VERA 2016
  • AVPT 2001
  • Country
  • VERA United States
  • AVPT United States
  • Employees
  • VERA N/A
  • AVPT N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • AVPT Computer Software: Prepackaged Software
  • Sector
  • VERA Health Care
  • AVPT Technology
  • Exchange
  • VERA Nasdaq
  • AVPT Nasdaq
  • Market Cap
  • VERA 2.0B
  • AVPT 3.9B
  • IPO Year
  • VERA 2021
  • AVPT N/A
  • Fundamental
  • Price
  • VERA $23.50
  • AVPT $18.67
  • Analyst Decision
  • VERA Buy
  • AVPT Buy
  • Analyst Count
  • VERA 8
  • AVPT 5
  • Target Price
  • VERA $64.63
  • AVPT $17.40
  • AVG Volume (30 Days)
  • VERA 1.5M
  • AVPT 1.3M
  • Earning Date
  • VERA 08-07-2025
  • AVPT 08-07-2025
  • Dividend Yield
  • VERA N/A
  • AVPT N/A
  • EPS Growth
  • VERA N/A
  • AVPT N/A
  • EPS
  • VERA N/A
  • AVPT N/A
  • Revenue
  • VERA N/A
  • AVPT $349,012,000.00
  • Revenue This Year
  • VERA N/A
  • AVPT $23.25
  • Revenue Next Year
  • VERA N/A
  • AVPT $18.07
  • P/E Ratio
  • VERA N/A
  • AVPT N/A
  • Revenue Growth
  • VERA N/A
  • AVPT 21.70
  • 52 Week Low
  • VERA $18.53
  • AVPT $9.38
  • 52 Week High
  • VERA $51.61
  • AVPT $20.25
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.21
  • AVPT 49.36
  • Support Level
  • VERA $22.57
  • AVPT $18.37
  • Resistance Level
  • VERA $24.26
  • AVPT $19.05
  • Average True Range (ATR)
  • VERA 1.14
  • AVPT 0.55
  • MACD
  • VERA 0.08
  • AVPT -0.07
  • Stochastic Oscillator
  • VERA 63.39
  • AVPT 45.85

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About AVPT AvePoint Inc.

AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.

Share on Social Networks: